Search Results
Biomarkers and Drug Development: Regulatory Perspective | Christopher Leptak
IBD Webinar 2021: Biomarkers & Drug Development- Regulatory Perspective
What Does Biomarker Qualification Do (And Not Do)?
Remote Digital Monitoring Workshop: Regulatory Guidance DDT - Chris Leptak & Panel Discussion
The Biomarker Qualification Process: A Roadmap for Requestors
2019 FNIH Biomarkers Consortium Neuroscience Symposium Session 1 - Multimodal Biomarkers
Translational biomarkers for CNS drug development, Mark Cunningham (Newcastle University, UK)
Early Drug Development Workshop on Building Effective Biomarker Plans
Pathways for Using Biomarkers in Drug Development
MDC Connects: Developing a Biomarker Strategy
#NIHHEAL: Endpoints for Pain Clinical Trials — Approaches & Accepted Endpoints for Biomarker Devices
FDA Regulations - Biomarkers
